1998
DOI: 10.1016/s1081-1206(10)62798-6
|View full text |Cite
|
Sign up to set email alerts
|

Clinical and Antiinflammatory Effects of Intranasal Budesonide Aqueous Pump Spray in the Treatment of Perennial Allergic Rhinitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2005
2005
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 37 publications
(18 citation statements)
references
References 23 publications
0
18
0
Order By: Relevance
“…The reduction in these inflammatory cells occurred at doses of 32 mg/d, 64 mg/d, 128 mg/d, and 256 mg/d. 120 Oral corticosteroids. Oral prednisone has been studied for its effect on the late nasal response to allergen challenge.…”
Section: Influence Of Therapeutic Intervention On Nasal Cytologymentioning
confidence: 99%
“…The reduction in these inflammatory cells occurred at doses of 32 mg/d, 64 mg/d, 128 mg/d, and 256 mg/d. 120 Oral corticosteroids. Oral prednisone has been studied for its effect on the late nasal response to allergen challenge.…”
Section: Influence Of Therapeutic Intervention On Nasal Cytologymentioning
confidence: 99%
“…Inhaled glucocorticosteroid treatment represents an efficacious approach for allergic rhinitis [9][10][11][12] reducing the edema of nasal mucosa and the experimental influx of inflammatory cells in the nose of allergic patients [1]. Indeed, treatment with intranasal glucocorticosteroids reduces the swelling of the nasal mucosa, which leads to airflow obstruction, and decreases the numbers of Langerhans cells, mast cells, eosinophils and T-cells in the upper airways of patients with intermittent or persistent allergic rhinitis [1,[9][10][11][12].…”
Section: Introductionmentioning
confidence: 99%
“…Indeed, treatment with intranasal glucocorticosteroids reduces the swelling of the nasal mucosa, which leads to airflow obstruction, and decreases the numbers of Langerhans cells, mast cells, eosinophils and T-cells in the upper airways of patients with intermittent or persistent allergic rhinitis [1,[9][10][11][12].…”
Section: Introductionmentioning
confidence: 99%
“…A difference between treatments in conventional clinical rhinitis trials of a 0.5 score step on a 0 to 9 scale (composite of blockage, secretion, and sneezing) can be detected with reasonable numbers of patients and has been considered a clinically relevant magnitude of efficacy. 12,13 The clinical relevance will of course depend on the starting reference symptom score, because a change from 1.0 to 0.5 might be considered a more relevant reduction than that from 8.0 to 7.5, even if both were statistically significant. Insufficient attention has been given to the magnitude of change in relationship to the baseline scores in the presentation of results.…”
Section: Significance Of Findingsmentioning
confidence: 99%